RHUMBLINE ADVISERS

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1115418 BOSTON, MA

Position in PRAX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$10,593,285

+$2,245,070 QoQ

Shares Held

32,879

+16.1% QoQ

Ownership

0.118%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 17.61002463578576.ToString("F0")% Shared 0.ToString("F0")% None 82.38997536421424.ToString("F0")%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. PRAX ranks #26 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	423,140	$188,948,935
2	REGN	Regeneron Pharmaceuticals, Inc.	157,781	$121,907,911
3	INCY	Incyte Corp	693,665	$65,287,749
4	ALNY	Alnylam Pharmaceuticals, Inc.	195,277	$64,611,300
5	INSM	INSMED Inc	272,615	$44,578,004
6	JAZZ	Jazz Pharmaceuticals plc	164,542	$31,106,665
7	EXEL	Exelixis, Inc.	723,931	$31,049,400
8	ROIV	Roivant Sciences Ltd.	1,113,266	$30,837,468

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,593,285	32,879	+16.1%	Shares	Sole	2026-05-12
2025-12-31	$8,348,215	28,324	+5.7%	Shares	Sole	2026-02-13
2025-09-30	$1,420,082	26,794	-2.0%	Shares	Sole	2025-11-06
2025-06-30	$1,149,689	27,341	+12.5%	Shares	Sole	2025-08-12
2025-03-31	$920,013	24,294	+6.7%	Shares	Sole	2025-05-29
2024-12-31	$1,752,302	22,769	-1.5%	Shares	Sole	2025-05-29
2024-09-30	$1,330,094	23,116	+4.2%	Shares	Sole	2024-11-12
2024-06-30	$917,861	22,192	+14500.0%	Shares	Sole	2024-08-01
2024-03-31	$9,275	152	0.0%	Shares	Sole	2024-05-09
2023-12-31	$3,386	152	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.